Multi-dimensional image reconstruction and analysis for expert-system diagnosis
AssigneeSpectrum Dynamics LLC
InventorsBenny Rousso, Dalia Dickman, Michael Nagler, Shankar Vallabhajosula
Life of this patent
Estimating the term…
Abstract
An electronic storage medium that comprises at least one radiopharmaceutical identity, SPECT measured values of at least one radiopharmaceutical kinetic parameter of a flow rate across a tissue membrane, for the radiopharmaceutical, and a set of instructions for associating the at least one radiopharmaceutical kinetic parameter with a disease signature.
Claims22
A non-transitory tangible medium comprising
- at least one radiopharmaceutical identity;
- SPECT measured values of at least one radiopharmaceutical kinetic parameter of a flow rate across a tissue membrane, for the radiopharmaceutical, and
- a set of instructions for associating the at least one radiopharmaceutical kinetic parameter with a disease signature.
Apparatus for performing automatic diagnosis, based on SPECT data, comprising at least one computer usable non-transitory tangible medium having a computer readable program code embodied therein, said computer readable program code adapted to be executed to implement a set of instructions for:
- providing pathological signatures, each characterized by a unique combination of at least two patient parameters, at least one of which relating to behavior of a radiopharmaceutical in vivo, as measured by SPECT;
- measuring the at least two patient parameters, wherein the at least one patient parameter relating to the behavior of the radiopharmaceutical in vivo is measured by SPECT imaging;
- and
- automatically diagnosing a pathology by automatically matching the at least two patient parameters and the pathological signatures.
A non-transitory tangible medium comprising a set of instructions for:
- providing pathological signatures, each characterized by a unique combination of at least two patient parameters, at least one of which relating to behavior of a radiopharmaceutical in vivo, as measured by SPECT;
- measuring the at least two patient parameters, wherein the at least one patient parameter relating to the behavior of the radiopharmaceutical in vivo is measured by SPECT imaging;
- and
- automatically diagnosing a pathology by automatically matching the at least two patient parameters and the pathological signatures.
Dependencies are inferred from the claim text.